|Articles|November 14, 2008

2009 Media Kit

{!-- --}

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

2009 Media Kit

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Trending on Medical Economics

McKesson data breach exposes prescribing physicians and their patients to fallout from a third-party attack

Primary care cuts the financial and human cost of chronic disease. So why isn’t the nation investing in it?

Kennedy asks the public to weigh in on the AMA's control of codes by Sept. 14

Lifestyle medicine could be direct primary care's next differentiator, whitepaper says

What physicians can actually do about a fake or defamatory online review